| Patents for A61P 1 - Drugs for disorders of the alimentary tract or the digestive system (125,798) |
|---|
| 06/27/2006 | US7067476 Peptide derivative containing hydroxy or carbonyl groups and a residue of arganine and lysine side chain in which guanidino and amino groups are protected; used for periodontal disease |
| 06/27/2006 | US7067307 Bioractor for propagation ad storage of liver cells |
| 06/27/2006 | US7067281 Mammalian IAP gene family, primers, probes and detection methods |
| 06/27/2006 | US7067247 Comprises mutant hepatitis B surface antigen for detecting viral diseases; immunoassays; kidney disorders |
| 06/27/2006 | US7067161 Animal food supplement compositions and methods of use |
| 06/27/2006 | CA2408909C Azabicyclo[3.2.1]octane triazolyl tropane derivatives as ccrs5 modulators |
| 06/22/2006 | WO2006064945A1 Process for producing muscarine receptor antagonist and intermediate therefor |
| 06/22/2006 | WO2006064914A1 Neuraminidase inhibitor |
| 06/22/2006 | WO2006064886A1 Agent for regulating bone formation |
| 06/22/2006 | WO2006064780A1 Therapeutic agent for constipation |
| 06/22/2006 | WO2006064779A1 Indolomorphinan derivative having carboxy in 6'-position |
| 06/22/2006 | WO2006064757A1 Aminocarboxylic acid derivative and medicinal use thereof |
| 06/22/2006 | WO2006064339A1 Chromane derivatives useful as acid pump antagonists |
| 06/22/2006 | WO2006063837A2 Use of bombesin/gastrin-releasing peptide antagonists for the treatment of inflammatory conditions, acute lung injury and bipolar disorder |
| 06/22/2006 | WO2006040047A3 Diagnostics and therapeutics for diseases associated with rho/rac-interacting citron kinase (cit) |
| 06/22/2006 | WO2006008008A3 Diagnostics and therapeutics for diseases associated with hepatocyte nuclear factor 4, alpha (hnf4a) |
| 06/22/2006 | WO2005101004A8 Diagnostics and therapeutics for diseases associated with purinoceptor 1 type y (p2y1) |
| 06/22/2006 | WO2005080397A8 Fused hetrocyclic compounds and their use as metabotropic receptor antagonists for the treatment of gastrointestinal disorders |
| 06/22/2006 | US20060136136 Crystal structure of baff, and use thereof in drug design |
| 06/22/2006 | US20060135776 4-Cyanopyrazole-3-carboxamide derivatives, preparation, and application thereof |
| 06/22/2006 | US20060135613 Carboxamides derivatives |
| 06/22/2006 | US20060135588 Preventive and/or therapeutic drugs for inflammatory intestinal diseases |
| 06/22/2006 | US20060135587 Method and compounds for promoting healing and reducing inflammation |
| 06/22/2006 | US20060135580 One step reaction of compound such as 3,5-dimethyl-isoxazole with butlyllithium and (3,5-di-tert-butyl)-4-hydroxybenzaldehyde, recrystallization/dehydration alcohol in the presence of a base to give (E)-5-[2-(3,5-di-tert-butyl-4-hydroxyphenyl)vinyl]-3-methylisoxazole |
| 06/22/2006 | US20060135572 Compounds as for example, 2'-[1-[(2R)-3-[[1-(3-fluoro-4-methylphenyl)-2-methylpropan-2-yl]amino]-2-hydroxypropoxy]ethyl]-3-methylbiphenyl-4-carboxylic acid, having a calcium-sensing receptor antagonistic action; therapeutic drug for osteoporosis |
| 06/22/2006 | US20060135566 E.g., N-[5-(2-Benzoylamino-4-pyridyl)-4-(3,5-dimethylphenyl)-1,3-thiazol-2-yl]acetamide,; the compounds have adenosine A3 receptor antagonistic activity, a p38 MAP kinase inhibitory action, and a TNF- alpha production-inhibitory action |
| 06/22/2006 | US20060135555 Ring fused pyrazole derivatives as CRF antagonists |
| 06/22/2006 | US20060135543 N4-(1,4-Benzoxazin-6-yl)-5-fluoro-N2-[3-(N-methylamino)carbonylmethyleneoxyphenyl]-2,4-pyrimidinediamine or a salt, hydrate, solvate and/or N-oxide; inhibit the IgE and/or IgG receptor signaling cascades that lead to the release of chemical mediators; Syk kinase inhibitors |
| 06/22/2006 | US20060135533 Compound preparation for dizziness |
| 06/22/2006 | US20060135525 Pyrazolopyrimidine compound and a process for preparing the same |
| 06/22/2006 | US20060135523 2-substituted 5,6-diaryl-pyrazine derivatives as cb1 modulator |
| 06/22/2006 | US20060135521 Administering racemic reboxetine or a salt thereof for inhibition of norepinephrine reuptake |
| 06/22/2006 | US20060135520 Method of treating peripheral neuropathy |
| 06/22/2006 | US20060135519 5-aryltetrazole compounds and compositions thereof |
| 06/22/2006 | US20060135502 Cyclic derivatives as modulators of chemokine receptor activity |
| 06/22/2006 | US20060135471 Anti-obesity compositions |
| 06/22/2006 | US20060135415 Immunomodulation and effect on cell processes relating to serotonin family receptors and the blood-brain barrier |
| 06/22/2006 | US20060135411 Administering an effective amount of the compound AcPhe[Orn-Pro-D-Cyclohexylalanine-Trp-Arg] to a subject in need thereof; cyclic peptidic and peptidomimetic compounds have the ability to modulate the activity of G protein-coupled receptors |
| 06/22/2006 | US20060135407 Phosphoprotein preparations for bioactive metal ion delivery and teeth remineralisation |
| 06/22/2006 | US20060134719 Novel serine protease |
| 06/22/2006 | US20060134286 Gallocatechin gallate-containing composition |
| 06/22/2006 | US20060134101 Use of avian antibodies |
| 06/22/2006 | US20060134090 Method and dietary composition for improving lipid digestibility |
| 06/22/2006 | US20060134082 Mammalian animal compositon |
| 06/22/2006 | US20060134011 Oral and dental composition |
| 06/22/2006 | CA2594987A1 Therapeutic agent for constipation |
| 06/22/2006 | CA2591715A1 Agent for regulating bone formation |
| 06/22/2006 | CA2591412A1 Chromane derivatives useful as acid pump antagonists |
| 06/22/2006 | CA2591399A1 Aminocarboxylic acid derivative and medicinal use thereof |
| 06/22/2006 | CA2590182A1 Indolomorphinan derivatives having carboxy at the 6'-position |
| 06/21/2006 | EP1672065A1 Protein expressed in nk cell |
| 06/21/2006 | EP1671973A2 Allosteric adenosine receptor modulators |
| 06/21/2006 | EP1671965A2 Oxacarbocyclic oligomers of fumaric acid |
| 06/21/2006 | EP1671961A1 Cinnamoyl compound and use of the same |
| 06/21/2006 | EP1671950A1 Cinnamoyl derivatives and use thereof |
| 06/21/2006 | EP1671948A1 Cinnamoyl compound and use of the same |
| 06/21/2006 | EP1671643A1 Medicinal composition for treating chronic hepatitis c |
| 06/21/2006 | EP1671641A1 Remedy and therapeutic method for periodontal diseases and pulpal diseases |
| 06/21/2006 | EP1671636A1 5-aminosalicylic acid solid preparation improved in discoloration and method of storing the same |
| 06/21/2006 | EP1671632A1 Pharmaceutical combination of angiotensin II antagonists and ACE inhibitors |
| 06/21/2006 | EP1671629A1 Human beta-defensin secretion promoter |
| 06/21/2006 | EP1671625A1 Nanoparticles |
| 06/21/2006 | EP1670795A1 Pharmacologically active imidazo 4,5-c pyridines |
| 06/21/2006 | EP1670494A1 Glatiramer acetate for use as an immuno-modulatory agent |
| 06/21/2006 | EP1670481A1 Use of ciclesonide for the treatment of inflammatory bowel diseases |
| 06/21/2006 | EP1670467A1 Methods and compositions for the oral administration of prodrugs of proton pump inhibitors |
| 06/21/2006 | EP1670418A2 Chitosan spinning method, device therefor, and resulting chitosan yarn, and uses thereof |
| 06/21/2006 | EP1443915B1 Pharmaceutical and cosmetic compositions containing oxy group-bearing aromatic aldehydes |
| 06/21/2006 | EP1437126B1 Compositions used to alleviate xerostomia and to treat disorders associated with same |
| 06/21/2006 | EP1366049B1 Pirazino¬1'2':1,6|pyrido¬3,4-b|indole derivatives |
| 06/21/2006 | EP1284952B1 Substituted chalcones as therapeutic compounds |
| 06/21/2006 | EP1282599B1 Disulfide derivatives useful for treating allergic diseases |
| 06/21/2006 | EP1268419B1 Pyrrolidine derivatives useful as bax inhibitors |
| 06/21/2006 | EP1208092B1 Sulfonamide derivative as a matrix metalloproteinase inhibitor |
| 06/21/2006 | EP1192185B1 Apo-2L RECEPTOR AGONIST AND CPT-11 SYNERGISM |
| 06/21/2006 | EP1049662B1 Inhibitors of alpha4 mediated cell adhesion |
| 06/21/2006 | EP1025106B1 Allosteric adenosine receptor modulators |
| 06/21/2006 | CN1791594A 2-aminoquinoline derivative |
| 06/21/2006 | CN1791425A C1 inhibitor with short half-life for transient treatment |
| 06/21/2006 | CN1791406A Solid state forms of 5-(difluoro-methoxy)-2-((3,4-dimethoxy-2-pyridinyl)-methyl) sulfinyl]-1H-benzimidazole sodium aquo complexes |
| 06/21/2006 | CN1791400A Composition for lowering lipid in body |
| 06/21/2006 | CN1791394A Preventive and/or therapeutic agent for inflammatory bowel disease |
| 06/21/2006 | CN1789251A Process for preparing razole series heterocyclic compound and salts thereof |
| 06/21/2006 | CN1788789A Anti-inflammatory action of oxidation type extrasin beta-10 |
| 06/21/2006 | CN1788788A Preparation method of granule for strengthening middle-burner and benefiting vital energy and the granule therefrom |
| 06/21/2006 | CN1788783A Granule containing ginseng ,Siberian cocklebur ,lagehead atractylodes and its preparation method |
| 06/21/2006 | CN1788779A Body-strengthening conditioning agent for fowl and livestock |
| 06/21/2006 | CN1788778A Medicine for treating hepatitis and its preparing process |
| 06/21/2006 | CN1788773A Traditional Chinese medicine preparation for treating liver disease and its preparation process |
| 06/21/2006 | CN1788772A Traditional Chinese medicine oral liquid for building spleen and kidney, nourishing heart and calming nerve |
| 06/21/2006 | CN1788767A 'Jiushendan' for fighting against senium |
| 06/21/2006 | CN1788752A Composite traditional Chinese herb formulation for preventing and treating gastrointestinal disease for fowl and livestock, and its preparation method and uses |
| 06/21/2006 | CN1788751A A group of injection composition containing glossy privet fruit and astragalus root for strengthening the body resistance |
| 06/21/2006 | CN1788745A Traditional Chinese medicine for stomach dynamic |
| 06/21/2006 | CN1788744A Ciliate desert-grass effective parts formulation resin processing method |
| 06/21/2006 | CN1788737A Coagulated bacillus living formulation preparation method and uses for treating ulcerative colitis |
| 06/21/2006 | CN1788732A Use of kutkin I in preparing drug for treating hepatitis B, its formulation and preparation method |
| 06/21/2006 | CN1788622A Health drink possessing liver harmonization and qi dredging function |
| 06/21/2006 | CN1260227C 5-membered ring heterocyclic compounds with nitrogen |
| 06/21/2006 | CN1260226C Tetrahydro-(benzo or thieno)-azepine-pyrazine and triazine derivatives as mGluR1 antagonists |